Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Onsite Tobacco Cessation Treatment for Patients With Peripheral Artery Disease (PAD): A Feasibility Study

NCT05469698 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT05469698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05469698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Onsite Tobacco Cessation Treatment for Patients With Peripheral Artery Disease (PAD): A Feasibility Study
Lead sponsor
University of Oklahoma
Phase
Not applicable
Overall status
Unknown status
Start date
August 16, 2022
Completion date
July 31, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease, tobacco cessation